BARCLAYS PLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,449
-7.5%
757,951
+43.1%
0.00%0.0%
Q2 2023$3,730
+46.3%
529,592
+27.0%
0.00%
+100.0%
Q1 2023$2,550
-36.8%
417,160
-33.9%
0.00%
-50.0%
Q4 2022$4,033
-99.9%
630,950
+61.5%
0.00%
-50.0%
Q3 2022$3,742,000
+681.2%
390,606
+799.7%
0.00%
Q2 2022$479,000
-60.8%
43,415
-40.7%
0.00%
-100.0%
Q1 2022$1,221,000
+435.5%
73,264
+515.5%
0.00%
Q4 2021$228,000
-70.0%
11,904
-61.5%
0.00%
Q3 2021$761,000
-67.6%
30,890
-65.8%
0.00%
-100.0%
Q2 2021$2,350,000
+8.5%
90,263
+32.0%
0.00%0.0%
Q1 2021$2,166,000
-29.9%
68,394
+2.7%
0.00%
-50.0%
Q4 2020$3,090,000
+59.2%
66,573
+12.9%
0.00%
+100.0%
Q3 2020$1,941,000
-63.2%
58,956
-69.4%
0.00%
-75.0%
Q2 2020$5,281,000
+44.8%
192,379
+57.9%
0.00%
+33.3%
Q1 2020$3,648,000
-38.3%
121,816
-43.0%
0.00%0.0%
Q4 2019$5,915,000
+207.9%
213,681
+102.5%
0.00%
+200.0%
Q3 2019$1,921,000
+4.5%
105,512
+40.8%
0.00%0.0%
Q2 2019$1,838,000
+244.2%
74,934
+33.7%
0.00%
Q1 2019$534,000
-0.9%
56,028
+17.1%
0.00%
Q3 2018$539,000
+222.8%
47,860
+267.8%
0.00%
Q2 2018$167,000
-42.6%
13,014
-24.6%
0.00%
Q1 2018$291,000
+1.7%
17,261
-51.8%
0.00%
Q4 2017$286,000
+1044.0%
35,799
+1006.3%
0.00%
Q3 2017$25,0003,236
+7990.0%
0.00%
Q2 2017$0400.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders